Insider trade

Ventas (VTR)CEO sold ~$179K

Peter J. Bulgarelli, CEO at Ventas, sold ~$179K of Ventas shares.

~$179K
Approx. value · 2,229 sh @ $80.08
106K
Holds after · shares reported
Traded
Nov 19, 2025
Filed
Nov 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 30, 2025InsiderCEO sold ~$143K of VTR shares in the open market
  2. Oct 1, 2025Insider · 2 peopleInsiders: 2 sales (~$904K)
  3. Oct 20, 2025Insider · 1 personInsiders: 2 sales (~$15.7M)
  4. Oct 29, 2025Company filing · Form 8-K · ResultsReported its results
  5. Oct 30, 2025Insider · 1 personInsiders: 4 sales (~$23.6M)
  6. Nov 3, 2025Insider · 1 personInsiders: 2 sales (~$1.5M)
  7. Nov 4, 2025Insider · 2 peopleInsiders: 2 sales (~$1.2M)
  8. Nov 5, 2025Insider · 2 peopleInsiders: 2 sales (~$1.5M)
  9. Nov 6, 2025Insider · 2 peopleInsiders: 2 sales (~$32K)
  10. Nov 7, 2025InsiderCEO sold ~$3K of VTR shares in the open market
  11. Nov 12, 2025InsiderCFO sold ~$2.58M of VTR shares in the open market
  12. Nov 12, 2025CongressDisclosed purchase of VTR — reported range $1,001 - $15,000
  13. Nov 14, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 17, 2025, Ventas, Inc. (the “Company”) announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc., is expected to retire effective as of May 1, 2026 (the “Effective Date”).”
  14. Nov 17, 2025InsiderCEO sold ~$3.26M of VTR shares in the open market
  15. Nov 18, 2025InsiderCEO sold ~$222K of VTR shares in the open market
  16. Nov 19, 2025 · this disclosureInsiderCEO sold ~$179K of VTR shares in the open market

What came next

  1. Dec 1, 2025InsiderCEO sold ~$831K of VTR shares in the open market
  2. Jan 2, 2026Insider · 2 peopleInsiders: 2 sales (~$3.1M)
  3. Jan 7, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  4. Jan 9, 2026CongressDisclosed partial sale of VTR — reported range $1,001 - $15,000
  5. Jan 21, 20265% stakeJPMORGAN CHASE & CO. reported a passive stake (13G) of 5.9%
  6. Feb 2, 2026InsiderCEO sold ~$802K of VTR shares in the open market
  7. Feb 5, 2026Company filing · Form 8-K · ResultsReported its results
  8. Feb 6, 2026InsiderCEO sold ~$849K of VTR shares in the open market
  9. Feb 11, 2026Insider · 5 days before an 8-KOfficer sold ~$3.02M of VTR shares in the open market
  10. Feb 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 16, 2026, Gregory R. Liebbe, Senior Vice President, Chief Accounting Officer and Controller informed Ventas, Inc. (the “Company”) that he is resigning to pursue other opportunities.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ventas

For Ventas, OQRO holds 1 Congress trade report and 16 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VTR page.

Other recent filings by Peter J. Bulgarelli, EVP OM&R-Ventas/Pres&CEO-LHS

The full history of Peter J. Bulgarelli, EVP OM&R-Ventas/Pres&CEO-LHS is on the profile page.

How this filing works

Other disclosures at Ventas

Everything OQRO holds on this company is on its VTR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data